Src regulates angiogenic factors and vascular permeability after focal cerebral ischemia-reperfusion

Neuroscience

Volumn 262, Issue , 2014, Pages 118-128

  Zan, L ^a   Zhang, X ^a   Xi, Y ^a   Wu, H ^b   Song, Y ^c   Teng, G ^d   Li, H ^b   Qi, J ^b   Wang, J ^e  

^a SHANXI CANCER HOSPITAL   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^d People's Hospital of Lixia District of Jinan   (China)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenic factors; Cerebral ischemia; PP1; Src; Vascular permeability; Zonula occludens 1

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; MESSENGER RNA; PROTEIN ZO1; REGULATOR PROTEIN; SRC PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; 4-AMINO-5-(4-METHYLPHENYL)-7-(TERT-BUTYL)PYRAZOLO(3,4-D)PYRIMIDINE; ANGPT1 PROTEIN, RAT; ENZYME INHIBITOR; PROTEIN TYROSINE KINASE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; TJP1 PROTEIN, RAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION; REPERFUSION INJURY; SRC GENE; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; BRAIN EDEMA; CAPILLARY PERMEABILITY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; ENZYME INHIBITORS; GENE EXPRESSION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; PHOSPHORYLATION; PYRAZOLES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, MESSENGER; SRC-FAMILY KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84893374236     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.12.060     Document Type: Article

References (28)

1. Albayrak S., Zhao Q., Siesjo B.K., Smith M.L. Effect of transient focal ischemia on blood-brain barrier permeability in the rat: correlation to cell injury. Acta Neuropathol 1997, 94:158-163.
2. Ardizzone T.D., Zhan X., Ander B.P., Sharp F.R. SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage. Stroke 2007, 38:1621-1625.
3. Asahara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M., Yancopoulos G.D., Isner J.M. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998, 83:233-240.
4. Brown M.T., Cooper J.A. Regulation, substrates and functions of src. Biochim Biophys Acta 1996, 1287:121-149.
5. Cole D.J., Matsumura J.S., Drummond J.C., Schultz R.L., Wong M.H. Time- and pressure-dependent changes in blood-brain barrier permeability after temporary middle cerebral artery occlusion in rats. Acta Neuropathol 1991, 82:266-273.
6. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1169.
7. Dvorak H.F., Nagy J.A., Feng D., Brown L.F., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999, 237:97-132.
8. Fischer S., Wobben M., Marti H.H., Renz D., Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 2002, 63:70-80.
9. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
10. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 1996, 271:695-701.
11. Kusaka G., Ishikawa M., Nanda A., Granger D.N., Zhang J.H. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004, 24:916-925.
12. Lauren J., Gunji Y., Alitalo K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?. Am J Pathol 1998, 153:1333-1339.
13. Lennmyr F., Ericsson A., Gerwins P., Akterin S., Ahlstrom H., Terent A. Src family kinase-inhibitor PP2 reduces focal ischemic brain injury. Acta Neurol Scand 2004, 110:175-179.
14. Liu Y., Bishop A., Witucki L., Kraybill B., Shimizu E., Tsien J., Ubersax J., Blethrow J., Morgan D.O., Shokat K.M. Structural basis for selective inhibition of Src family kinases by PP1. Chem Biol 1999, 6:671-678.
15. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
16. Paul R., Zhang Z.G., Eliceir B.P., Jiang Q., Boccia A.D., Zhang R.L., Chopp M., Cheresh D.A. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001, 7:222-227.
17. Pfaff D., Fiedler U., Augustin H.G. Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking. J Leukoc Biol 2006, 80:719-726.
18. Risau W., Esser S., Engelhardt B. Differentiation of blood-brain barrier endothelial cells. Pathol Biol (Paris) 1998, 46:171-175.
19. Schlessinger J. New roles for Src kinases in control of cell survival and angiogenesis. Cell 2000, 100:293-296.
20. Schoch H.J., Fischer S., Marti H.H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002, 125:2549-2557.
21. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
22. Tang X., Feng Y., Ye K. Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-kinase enhancer-activating Akt, preventing its apoptotic cleavage and promoting cell survival. Cell Death Differ 2007, 14:368-377.
23. Theus M.H., Wei L., Francis K., Yu S.P. Critical roles of Src family tyrosine kinases in excitatory neuronal differentiation of cultured embryonic stem cells. Exp Cell Res 2006, 312:3096-3107.
24. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997, 13:513-609.
25. Wang J., Dore S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 2007, 130:1643-1652.
26. Wang W., Dentler W.L., Borchardt R.T. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 2001, 280:H434-440.
27. Yang G.Y., Betz A.L. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994, 25:1658-1664. [discussion 1664-1655].
28. Zan L., Wu H., Jiang J., Zhao S., Song Y., Teng G., Li H., Jia Y., Zhou M., Zhang X., Qi J., Wang J. Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edema. Neurochem Int 2011, 58:872-879.